Clinical relevance of substitutions in the connection subdomain and RNase H domain of HIV-1 reverse transcriptase from a cohort of antiretroviral treatment-naïve patients
- 21 February 2009
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 82 (3) , 115-121
- https://doi.org/10.1016/j.antiviral.2009.02.189
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- HIV-1 reverse transcriptase connection subdomain mutations reduce template RNA degradation and enhance AZT excisionProceedings of the National Academy of Sciences, 2008
- Connection Domain Mutations N348I and A360V in HIV-1 Reverse Transcriptase Enhance Resistance to 3′-Azido-3′-deoxythymidine through Both RNase H-dependent and -independent MechanismsJournal of Biological Chemistry, 2008
- Dynamic binding orientations direct activity of HIV reverse transcriptaseNature, 2008
- Amino Acid Mutation N348I in the Connection Subdomain of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Confers Multiclass Resistance to Nucleoside and Nonnucleoside Reverse Transcriptase InhibitorsJournal of Virology, 2008
- Broad Antiretroviral Activity and Resistance Profile of the Novel Human Immunodeficiency Virus Integrase Inhibitor Elvitegravir (JTK-303/GS-9137)Journal of Virology, 2008
- Mechanisms by Which the G333D Mutation in Human Immunodeficiency Virus Type 1 Reverse Transcriptase Facilitates Dual Resistance to Zidovudine and LamivudineAntimicrobial Agents and Chemotherapy, 2008
- Variations in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Are Associated with Divergent Phenotypic Resistance to ZidovudineAntimicrobial Agents and Chemotherapy, 2007
- Mutations in Human Immunodeficiency Virus Type 1 RNase H Primer Grip Enhance 3′-Azido-3′-Deoxythymidine ResistanceJournal of Virology, 2007
- Mutations in the connection domain of HIV-1 reverse transcriptase increase 3′-azido-3′-deoxythymidine resistanceProceedings of the National Academy of Sciences, 2007
- Genotypic predictors of human immunodeficiency virus type 1 drug resistanceProceedings of the National Academy of Sciences, 2006